Clinical Trial News and Research

RSS

Virtualscopics reports record revenues in first quarter 2014

VirtualScopics, Inc., a leading provider of quantitative imaging solutions, today reported the financial results for the first quarter ended March 31, 2014.

15 May 2014

Kamada to present Phase 2/3 clinical trial results of AAT to treat alpha-1 antitrypsin deficiency

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.

15 May 2014

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

A novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis (PVNS), a rare neoplastic joint disorder, according to new phase I data from Memorial Sloan Kettering Cancer Center and other institutions highlighted to media today in advance of the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), which will take place from May 30 to June 3 in Chicago.

15 May 2014

‘Lessebo’ effect implications for Parkinson’s therapies

Patients with Parkinson’s disease have a reduced objective response to treatment given in a clinical trial if they know they may be taking a placebo, research shows.

14 May 2014

Retrophin reports net loss of $70.6 million for first quarter 2014

Retrophin, Inc. today reported its financial results for the quarter ended March 31, 2014.

14 May 2014

Aradigm reports total revenue of $6.6 million for Q1 2014

Aradigm Corporation today announced financial results for the first quarter and three months ended March 31, 2014.

14 May 2014

Eagle Pharmaceuticals total revenue increases by $2.5 million for Q2 2014

Eagle Pharmaceuticals, Inc. today announced its financial results for the three-month period ended March 31, 2014. This marks the first period for which Eagle is reporting financial results as a public company.

14 May 2014

Minimally invasive TAVR procedure saves more lives than open-heart surgery, shows study

For the first time, a minimally invasive transcatheter valve - tested by Baylor Research Institute in Dallas (BRI) - has been shown to save more lives than open-heart surgery, according to new research revealed at the American College of Cardiology's 2014 Scientific Sessions and published in The New England Journal of Medicine.

From Medtronic 14 May 2014

CNS stimulant no more effective than placebo for alleviating lung cancer fatigue

Patients with advanced non-small-cell lung cancer who received the central nervous system stimulant modafinil reported no greater reduction in fatigue than patients given placebo, show study results.

13 May 2014

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

Da Volterra, a leading biopharmaceutical company in the field of bacterial resistance, announces today very promising new results about DAV132 in the prevention of the side effects of antibiotics and the occurrence of severe Clostridium difficile infections.

13 May 2014

New study presents novel strategy for treating multiple myeloma

A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) provides evidence that genetically modifying immune cells might effectively treat multiple myeloma, a disease that remains incurable and will account for an estimated 24,000 new cases and 11,100 deaths in 2014

13 May 2014

University of Chicago receives $3.9M award to serve as Lead Academic Participating Site for NCTN

A team from the University of Chicago Medicine Comprehensive Cancer Center has received a five-year, $3.9-million award from the National Cancer Institute to serve as a Lead Academic Participating Site for the newly created National Clinical Trials Network (NCTN).

13 May 2014

Beaumont Children's Hospital wins grant from CureSearch Children's Cancer to help fund therapeutic clinical trials

CureSearch for Children's Cancer has awarded a $20,000 grant to Beaumont Children's Hospital to help fund therapeutic clinical trials.

13 May 2014

Leadless pacemaker technology shows promising performance after 12 months

Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported his promising12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional pacemakers. Dr. Reddy presented the one-year LEADLESS study data findings during his late-breaking clinical trial presentation on May 9 at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions in San Francisco, CA.

12 May 2014

Akebia Therapeutics reports net loss of $9.7 million for Q1 2014

Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced financial results for the first quarter ended March 31, 2014.

12 May 2014

Foundation Medicine obtains CE mark for FoundationOne

Foundation Medicine, Inc. today announced that it has obtained a CE mark for FoundationOne®. The CE mark allows FoundationOne to be placed on the market in the European Economic Area.

12 May 2014

Verastem announces expansion of ongoing COMMAND study in Japan

Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the expansion of its ongoing COMMAND study to include clinical trial sites in Japan.

12 May 2014

Pfizer reports positive results from rLP2086 Phase 2 study for invasive meningococcal disease

Pfizer Inc. announced today the results from two Phase 2 studies of bivalent rLP2086, Pfizer's recombinant vaccine candidate, currently under development for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 to 25 year olds.

12 May 2014

Flatiron Health agrees to acquire Altos Solutions

Altos Solutions, creators of OncoEMR, the first web-based oncology-specific electronic medical record, today announced an agreement to be acquired by Flatiron Health.

9 May 2014

Patients with Parkinson's disease show improvements after exenatide therapy

Follow-Up Study Published in the Journal of Parkinson's Disease Supports an Earlier "Proof of Concept" Trial. A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy.

9 May 2014

Clinical Trial News and Research

Virtualscopics reports record revenues in first quarter 2014

Kamada to present Phase 2/3 clinical trial results of AAT to treat alpha-1 antitrypsin deficiency

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

‘Lessebo’ effect implications for Parkinson’s therapies

Retrophin reports net loss of $70.6 million for first quarter 2014

Aradigm reports total revenue of $6.6 million for Q1 2014

Eagle Pharmaceuticals total revenue increases by $2.5 million for Q2 2014

Minimally invasive TAVR procedure saves more lives than open-heart surgery, shows study

CNS stimulant no more effective than placebo for alleviating lung cancer fatigue

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

New study presents novel strategy for treating multiple myeloma

University of Chicago receives $3.9M award to serve as Lead Academic Participating Site for NCTN

Beaumont Children's Hospital wins grant from CureSearch Children's Cancer to help fund therapeutic clinical trials

Leadless pacemaker technology shows promising performance after 12 months

Akebia Therapeutics reports net loss of $9.7 million for Q1 2014

Foundation Medicine obtains CE mark for FoundationOne

Verastem announces expansion of ongoing COMMAND study in Japan

Pfizer reports positive results from rLP2086 Phase 2 study for invasive meningococcal disease

Flatiron Health agrees to acquire Altos Solutions

Patients with Parkinson's disease show improvements after exenatide therapy

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Event guide: 2nd World RNA-Based Therapeutics & Vaccines Summit Korea

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery